1. CLINICAL FEATURES, TREATMENT AND OUTCOME OF NEUROLYMPHOMATOSIS: SINGLE INSTITUTION EXPERIENCE. (12th June 2019) Authors: Novo, M.; Nowakowski, G.S.; Micallef, I.N.; Ristow, K.; Habermann, T.M.; Johnston, P.B. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PERSISTENT MEDIASTINAL POSITRON EMISSION TOMOGRAPHY (PET)‐POSITIVITY AFTER FRONTLINE THERAPY FOR HODGKIN LYMPHOMA IS BEST MANAGED BY CLOSE OBSERVATION. (12th June 2019) Authors: Novo, M.; Nowakowski, G.S.; Habermann, T.M.; Witzig, T.E.; Micallef, I.N.; Johnston, P.B.; Inwards, D.J.; Ristow, K.; Young, J.R.; Ansell, S.M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗